Symbol | Company | Weighting |
---|---|---|
GH | GUARDANT HEALTH INC | 3.10% |
ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 2.62% |
INSM | INSMED INC | 2.51% |
SMMT | SUMMIT THERAPEUTICS INC. | 2.48% |
MRUS | MERUS NV | 2.36% |
AMLX | AMYLYX PHARMACEUTICALS INC | 2.27% |
MCK | MCKESSON CORP | 2.24% |
ABT | ABBOTT LABORATORIES | 2.19% |
BSX | BOSTON SCIENTIFIC | 2.15% |
THC | TENET HEALTHCARE CORP | 2.15% |
HCA | HCA HOLDINGS INC | 2.11% |
AXSM | AXSOME THERAPEUTICS INC. | 2.11% |
DXCM | DEXCOM INC | 2.08% |
AZN | ASTRAZENECA PLC-ADR | 2.05% |
PEN | PENUMBRA INC | 2.04% |
ISRG | INTUITIVE SURGICAL INC | 2.03% |
SYK | STRYKER CORP | 1.98% |
NBIX | NEUROCRINE BIOSCIENCES INC | 1.94% |
LLY | ELI LILLY CORP | 1.94% |
RMD | RESMED INC | 1.93% |
ALC | ALCON INC | 1.92% |
SNY | SANOFI- AVENTIS- ADR | 1.91% |
NAMS | NEWAMSTERDAM PHARMA CO NV | 1.87% |
CI | THE CIGNA GROUP | 1.79% |
ELV | ELEVANCE HEALTH INC | 1.74% |
BMRN | BIOMARIN PHARAMCEUTICAL INC | 1.73% |
ARGX | ARGENX SE ADR | 1.70% |
ZTS | ZOETIS INC | 1.69% |
ABVX | ABIVAX SA | 1.69% |
ARWR | ARROWHEAD PHARMACEUTICALS INC | 1.68% |
GEHC | GE HEALTHCARE TECHNOLOGIES INC | 1.67% |
NUVL | NUVALENT INC | 1.66% |
RARE | ULTRAGENYX PHARMACEUTICAL INC | 1.63% |
IDYA | IDEAYA BIOSCIENCES, INC | 1.62% |
TMO | THERMO FISHER SCIENTIFIC INC | 1.60% |
TVTX | TRAVERE THERAPEUTICS INC | 1.58% |
BIIB | BIOGEN INC | 1.58% |
CNTA | CENTESSA PHARMACEUTI | 1.58% |
MRK | MERCK & CO. NEW | 1.57% |
HUM | HUMANA INC | 1.50% |
MOH | MOLINA HEALTHCARE INC | 1.50% |
BDX | BECTON DICKINSON & CO | 1.43% |
ICLR | ICON PLC | 1.41% |
IMTX | IMMATICS NV | 1.38% |
COO | COOPER COS INC | 1.38% |
GKOS | GLAUKOS CORPORATION | 1.36% |
REGN | REGENERON PHARMACEUTICALS | 1.36% |
CYTK | CYTOKINETICS INC | 1.30% |
INSP | INSPIRE MEDICAL SYSTEMS, INC. | 1.29% |
RVMD | REVOLUTION MEDICINES INC | 1.26% |
IMVT | IMMUNOVANT INC | 1.22% |
NVO | NOVO NORDISK A/S | 1.21% |
SNDX | SYNDAX PHARMACEUTICALS, INC. | 1.06% |
TNDM | TANDEM DIABETES CARE INC | 1.05% |
UNH | UNITEDHEALTH GROUP INC | 0.96% |
EWTX | EDGEWISE THERAPEUTICS | 0.77% |
PCVX | VAXCYTE INC | 0.73% |
GERN | GERON CORP | 0.67% |
ARVN | ARVINAS INC USD | 0.66% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.